Upstream Bio Inc
UPB
NASDAQ
Biotechnology
$7.07
USD
+0.16 (+2.32%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $397.81M
Volume 688.2K
Price Target
$8.00 – $36.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $36.00 and a min estimate of $8.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$22.00
-$10.5 vs prior
Implied Upside
+211.2%
-148.5% vs prior
Analyst Covering
2
Unchanged vs prior period
Consensus
Hold
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
1 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Tessa Romero | JP Morgan | Hold | Downgraded | 2 months ago | Plus | Plus | Plus |
Matthew Caufield | HC Wainwright & Co. | Buy | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
